Linlin Li

508 citations
27 papers · 389 indexed · h-index 11
Topics
Radiopharmaceutical Chemistry and Applications (4 papers)Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers)Prostate Cancer Treatment and Research (4 papers)

In The Last Decade

Linlin Li

26 papers receiving 385 citations

Peers

Linlin Li
Comparison fields: 5 of 89
  • Pulmonary and Respiratory Medicine 134
  • Molecular Biology 116
  • Oncology 76
  • Cancer Research 52
  • Materials Chemistry 50
Replace Anna‐Karin Larsson‐Callerfelt with:
Anna‐Karin Larsson‐Callerfelt Sweden
Chang‐Woo Song South Korea
Mie Kainoh Japan
Jitao Chen China
Shiyong Qi China
Yan Meng China
Kaiwen Wang China
Guoqing Zhang China
Dipankar Ash United States
Linlin Li relative to Anna‐Karin Larsson‐Callerfelt Sweden Anna‐Karin Larsson‐Callerfelt's profile →
Citations per field
00.5×3.1×
Anna‐Karin Larsson‐Callerfelt · 1×
Citations per year

Countries citing papers authored by Linlin Li

Since Specialization
Citations

This map shows the geographic impact of Linlin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linlin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linlin Li more than expected).

Fields of papers citing papers by Linlin Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linlin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linlin Li. The network helps show where Linlin Li may publish in the future.

Co-authorship network of co-authors of Linlin Li

This figure shows the co-authorship network connecting the top 25 collaborators of Linlin Li. A scholar is included among the top collaborators of Linlin Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linlin Li. Linlin Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 3
3 8
4 14
5 1
6 2
7 4
8 10
9 2
10 6
11 4
12 4
13 17
14 11
15 19
16 20
17 46
18 48
19 107
20 1

About Linlin Li

Linlin Li is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 27 papers that have together received 389 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (4 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers) and Prostate Cancer Treatment and Research (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (134 citations), Biomaterials (48 citations) and Cancer Research (52 citations). Linlin Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Changhui Fu, Dong Chen, Fangqiong Tang, Huiyu Liu, Tianlong Liu, Jing Mao, Yange Tian, Hui Liu, Yongping Wu and Peng-jin Mei. Their work appears in journals such as PLoS ONE, Biomaterials and Food Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026